Physician profile
Leanne Lamb
NPI 1831912237
$1,086.83
in general payments reported to CMS, 2019-2025
10 companies · $953 in 2025
The $953 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $134 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,086.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $396.23 | 2024-2025 | Airsupra, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $266.78 | 2025 | Nucala, Trelegy Ellipta |
| Abbvie INC. | $149.54 | 2025 | |
| Novartis Pharmaceuticals Corporation | $72.30 | 2025 | |
| Genzyme Corporation | $71.73 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $45.71 | 2025 | Dupixent |
| Ars Pharmaceuticals Operations, INC. | $24.73 | 2025 | Neffy |
| 3b Medical, INC. | $23.70 | 2025 | Luna |
| Alk-Abello, INC | $21.07 | 2025 | Grastek, Odactra |
| Phathom Pharmaceuticals, INC. | $15.04 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leanne Lamb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.